<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Y</submitter><funding>National Key R&amp;D Program of China</funding><funding>STI2030-Major Projects</funding><funding>National Clinical Research Center for Geriatric Disorders</funding><funding>Xiangya Hospital</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Science and Technology Major Project of Hunan Province</funding><funding>National Key Research and Development Program of China</funding><funding>Science and Technology Innovation Program of Hunan Province</funding><funding>Xiangya Hospital, Central South University</funding><pagination>4841-4853</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11247675</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(7)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The cognitive impairment patterns and the association with Alzheimer's disease (AD) in mental disorders remain poorly understood.&lt;h4>Methods&lt;/h4>We analyzed data from 486,297 UK Biobank participants, categorizing them by mental disorder history to identify the risk of AD and the cognitive impairment characteristics. Causation was further assessed using Mendelian randomization (MR).&lt;h4>Results&lt;/h4>AD risk was higher in individuals with bipolar disorder (BD; hazard ratio [HR] = 2.37, P &lt; 0.01) and major depressive disorder (MDD; HR = 1.63, P &lt; 0.001). MR confirmed a causal link between BD and AD (OR&lt;sub>IVW &lt;/sub>= 1.098), as well as obsessive-compulsive disorder (OCD) and AD (OR&lt;sub>IVW &lt;/sub>= 1.050). Cognitive impairments varied, with BD and schizophrenia showing wide</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis.</pubmed_title><pmcid>PMC11247675</pmcid><funding_grant_id>2022M723554</funding_grant_id><funding_grant_id>2021SK1020</funding_grant_id><funding_grant_id>82001358</funding_grant_id><funding_grant_id>U22A20300</funding_grant_id><funding_grant_id>2021JJ41046</funding_grant_id><funding_grant_id>2021ZD0201803</funding_grant_id><funding_grant_id>2022LNJJ16</funding_grant_id><funding_grant_id>2023YFC3603700</funding_grant_id><funding_grant_id>82371434</funding_grant_id><funding_grant_id>2021RC3028</funding_grant_id><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Shen L</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Jiao B</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Xiao X</pubmed_authors><pubmed_authors>Yao R</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis.</name><description>&lt;h4>Introduction&lt;/h4>The cognitive impairment patterns and the association with Alzheimer's disease (AD) in mental disorders remain poorly understood.&lt;h4>Methods&lt;/h4>We analyzed data from 486,297 UK Biobank participants, categorizing them by mental disorder history to identify the risk of AD and the cognitive impairment characteristics. Causation was further assessed using Mendelian randomization (MR).&lt;h4>Results&lt;/h4>AD risk was higher in individuals with bipolar disorder (BD; hazard ratio [HR] = 2.37, P &lt; 0.01) and major depressive disorder (MDD; HR = 1.63, P &lt; 0.001). MR confirmed a causal link between BD and AD (OR&lt;sub>IVW &lt;/sub>= 1.098), as well as obsessive-compulsive disorder (OCD) and AD (OR&lt;sub>IVW &lt;/sub>= 1.050). Cognitive impairments varied, with BD and schizophrenia showing wide</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-26T14:16:03.096Z</modification><creation>2025-04-06T14:30:46.88Z</creation></dates><accession>S-EPMC11247675</accession><cross_references><pubmed>38860751</pubmed><doi>10.1002/alz.14049</doi></cross_references></HashMap>